PRAXIS PRECISION MEDICINES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 1.91 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1.91M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1.95M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1.88M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 2.07M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 1.91M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 1.95M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 1.88M shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 2.07M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 2.10M shares 10-Q · filed 2025-08-04 |
| 2025-03-31 | 2.05M shares 10-Q · filed 2025-05-02 |
| 2024-12-31 | 1.81M shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 1.83M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 1.13M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 1.08M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 666.16K shares 10-K · filed 2024-03-05 |
| 2023-09-30 | 9.88M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 10.11M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 10.49M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 8.64M shares 10-K · filed 2023-02-07 |
| 2022-09-30 | 8.96M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 9.83M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 7.86M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 6.47M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 6.41M shares 10-Q · filed 2021-11-03 |
| 2021-06-30 | 6.46M shares 10-Q · filed 2021-08-16 |
| 2021-03-31 | 6.50M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 5.79M shares 10-K · filed 2021-03-17 |
| 2020-09-30 | 5.81M shares 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |